Serum Level of Antibody against Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA Adducts in People Dermally Exposed to PAHs

Table 3

The serum level of anti-BPDE-DNA before and after the therapy (smokers).

CCT content	Anti-BPDE-DNA		Statistical significance of differences
	Before GT	After GT
CCT-3% (𝑛=11)	0.21 (0.18–0.28)	0.28 (0.20–0.31)	NS
CCT-5% (𝑛=14)	0.30 (0.24–0.38)	0.35 (0.25–0.45)	𝑃<𝟎.𝟎𝟓
Statistical significance of differences	NS	NS

Anti-BPDE-DNA values (expressed as the EI) are presented as median (lower–upper quartile) because of nonnormal data distribution; 𝑛: number of subjects; 𝑃: Wilcoxon matched-pairs test.